Altumomab pentetate
Altumomab pentetate (pronunciation: al-too-moe-mab pen-te-tate) is a monoclonal antibody used in the field of nuclear medicine for the detection of certain types of cancer.
Etymology
The term "Altumomab" is derived from Latin "altus" meaning "high" and "moma" which is an abbreviation for "monoclonal antibody". "Pentetate" is derived from the chemical compound pentetic acid, which is used in the formulation of this drug.
Usage
Altumomab pentetate is used as a radiopharmaceutical agent in the detection of gastrointestinal and pancreatic cancers. It is administered intravenously and works by binding to the carcinoembryonic antigen (CEA), a protein often overexpressed in these types of cancers.
Related Terms
- Monoclonal antibody
- Nuclear medicine
- Cancer
- Radiopharmaceutical
- Gastrointestinal cancer
- Pancreatic cancer
- Carcinoembryonic antigen
- Pentetic acid
See Also
External links
- Medical encyclopedia article on Altumomab pentetate
- Wikipedia's article - Altumomab pentetate
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski